Navigating tuberculosis drug discovery with target-based screening.


INTRODUCTION Mycobacterium tuberculosis kills more people than any other bacterial pathogen. New drugs are required to shorten the treatment time and provide a viable therapy for drug-resistant and latent forms of tuberculosis. The tuberculosis field has advanced considerably since the publication of the M. tuberculosis genome sequence. Today, researchers… (More)
DOI: 10.1517/17460441.2011.586999


Cite this paper

@article{Miller2011NavigatingTD, title={Navigating tuberculosis drug discovery with target-based screening.}, author={Christopher H Miller and Ronan F O'Toole}, journal={Expert opinion on drug discovery}, year={2011}, volume={6 8}, pages={839-54} }